z-logo
open-access-imgOpen Access
Central giant cell granuloma (CGCG) in childhood: surgical treatment by maintaining the tooth germs
Author(s) -
Rafael Correia Cavalcante,
Paola Fernanda Cotait de Lucas Corso,
Tuany Rayra Pinto Lisboa Dias,
Eduarda Schramm,
Paulo Henrique Couto Souza,
Nelson Luís Barbosa Rebellato,
Delson João da Costa,
Rafaela Scariot
Publication year - 2017
Publication title -
rsbo./rsbo
Language(s) - English
Resource type - Journals
eISSN - 1984-5685
pISSN - 1806-7727
DOI - 10.21726/rsbo.v14i1.636
Subject(s) - curettage , central giant cell granuloma , enucleation , medicine , lesion , etiology , mandible (arthropod mouthpart) , panoramic radiograph , radiography , surgery , ostectomy , dentistry , pathology , botany , biology , genus
Central Giant Cell Granuloma (CGCG) is a nonneoplastic benign process, of unknown etiology, more common in children and young adults. When aggressive, the lesion may result in considerable bone destruction and deformation. Oral and Maxillofacial surgery strongly depends on the nature of injury and it may vary from more conservative to more aggressive approach. Case report: The aim of the present study is to report and analyze, a giant cell central lesion in a 7-year-old patient on the right side of mandible body treated by surgical enucleation, curettage, and maintenance of the tooth germs. Discussion: In less aggressive lesions, curettage followed by radiographic monitoring is the most widely suggested treatment choice. However, the “gold standard” for aggressive and deforming lesions would be en-bloc resection with a safety margin. Most revisions show recurrence rates of 15 to 20%, thus clinical monitoring is necessary at least one year after the intervention. Conclusion: After 12 months, panoramic radiograph and computed tomography indicated new bone formation and no recurrence. In addition, good healing of soft tissues and correct eruption of the teeth #42, #43 and #44 were observed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here